News

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Read More

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read More

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read More

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read More

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read More

University of Waterloo Working with Southern Chiefs’ Organization and Manitoba Association of Optometrists to Co-develop Data Governance Policies for Eye Data

People have the right to a say in how their data is collected, managed, stored and used That’s the principle behind a new partnership that will...

Read More

World Council of Optometry and Alcon Launch Additional Video Tools for Dry Eye Wheel

The World Council of Optometry (WCO) and Alcon have released new online resources to help eye care professionals (ECPs) use their Dry Eye Wheel, a practical tool that helps with the diagnosis and treatment of dry eye disease.

Read More

Optometry Giving Sight Announces 2024 Grant Winners

This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

Read More

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Read More

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read More